The Food and Drug Administration recently approved the expanded use of a drug that could revolutionize life for people with complex food allergies, after trials from doctors based in Maryland.
Xolair, an injectable drug used to treat asthma, is now approved for people as young as one year old to help reduce dangerous food allergy symptoms like anaphylaxis.
“For those families whose life is completely restricted by the food allergy, meaning that they never would travel on vacation without a kitchenette, because they can’t eat out at restaurants, for those families, this is going to be life changing,” said Dr. Robert Wood, the director of pediatric allergy immunology and rheumatology at Johns Hopkins Children’s Center.
Read more (and listen) at WYPR.
